During the past decade, Lillestol Research Llc conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 45 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 32 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lillestol Research Llc" #1 sponsor was "Eli Lilly and Company" with 19 trials, followed by "Pfizer" with 17 trials sponsored, "NewAmsterdam Pharma" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lillestol Research Llc" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Cardiokine Biopharma, LLC" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Lillestol Research Llc" are "Type 2 Diabetes Mellitus" (8 trials), "Obesity" (7 trials), "Diabetes Mellitus, Type 2" (6 trials), "Type 2 Diabetes" (6 trials) and "Migraine" (5 trials). Many other conditions were trialed in "Lillestol Research Llc" in a lesser frequency.

Most popular intervention types in "Lillestol Research Llc" are "Drug" (70 trials), "Biological" (12 trials), "Other" (8 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "Tirzepatide" (7 trials), "Dulaglutide" (3 trials), "Obicetrapib" (3 trials) and "BNT162b2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lillestol Research Llc" are 79 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Lillestol Research Llc". undefined are not yet recruiting, 11 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Lillestol Research Llc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lillestol Research Llc, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".